Scarica l'app Stockscreener
9.38
5.16%
-0.51
Dopo l'orario di chiusura:
9.32
-0.06
-0.64%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MLTX Giù?
Forum
Previsione
Moonlake Immunotherapeutics Borsa (MLTX) Ultime notizie
Berger Montague PC Investigating Claims on Behalf of MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors After Class Action Filing - MarketScreener
MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) INVESTOR ALERT - GlobeNewswire
Rosen Law Firm Urges MoonLake Immunotherapeutics (NASDAQ: MLTX) Stockholders with Large Losses to Co - PharmiWeb.com
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman - PR Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages MoonLake - GlobeNewswire
MLTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of MoonLake Immunotherapeutics, Inc. Investors - GlobeNewswire
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics - FinancialContent
Rosen Law Firm Urges MoonLake Immunotherapeutics (NASDAQ: MLTX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Chief Financial Officer of MoonLake Immunotherapeutics Matthias Bodenstedt Buys 1.8% More Shares - simplywall.st
MLTX INVESTOR ALERT: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - WV News
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Stockholder Alert: Robbins LLP Informs MoonLake Immunotherapeutics Stockholders that a Class Action Lawsuit was Filed Against the Company - PR Newswire
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman - GlobeNewswire Inc.
MoonLake Immunotherapeutics (MLTX) Investors with - GlobeNewswire
MoonLake Immunotherapeutics Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – MLTX - FinancialContent
MoonLake Immunotherapeutics (MLTX) Investors with Substantial Losses Have Opportunity to Lead the MoonLake Class Action Lawsuit -- RGRD LLP - MarketScreener
MOONLAKE ALERT: Bragar Eagel & Squire, P.C. Announces that - GlobeNewswire
SHAREHOLDER ALERT: MoonLake Immunotherapeutics Sued For Securities Fraud by Block & Leviton LLP; December 15 Deadline To Seek To Serve As Lead Plaintiff - GlobeNewswire
Can MoonLake Immunotherapeutics stock beat analyst upgradesAnalyst Downgrade & High Conviction Trade Alerts - newser.com
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman - PR Newswire
How to interpret RSI for MoonLake Immunotherapeutics stockJuly 2025 Decliners & Capital Efficient Trade Techniques - newser.com
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Consensus Rating of “Hold” by Brokerages - Defense World
MLTX Investor News: If You Have Suffered Losses in MoonLake - GlobeNewswire
Levi & Korsinsky Investigates Possible Securities Fraud by MoonLake Immunotherapeutics (MLTX) - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MoonLake ImmunotherapeuticsMLTX - PR Newswire
Using AI based signals to follow MoonLake ImmunotherapeuticsEarnings Miss & AI Forecast Swing Trade Picks - newser.com
ATTENTION MoonLake Immunotherapeutics (MLTX) Investors: Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire
Rosen Law Firm Encourages MoonLake Immunotherapeutics Investors to Inquire About Securities Class Action InvestigationMLTX - Eastern Progress
Shareholders Alert: Investigation Into MoonLake Immunotherapeutics (MLTX)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
MLTX SECURITIES NOTICE: MoonLake Immunotherapeutics - GlobeNewswire
Why Are MoonLake's (MLTX) Trial Setbacks Raising New Questions About Management Credibility and Regulatory Risks? - simplywall.st
MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on - GuruFocus
2025-10-10 | MLTX INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics | NDAQ:MLTX | Press Release - Stockhouse
MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Gap UpShould You Buy? - MarketBeat
MLTX SECURITIES NOTICE: MoonLake Immunotherapeutics Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money - GlobeNewswire
CFO Makes Bold Move with Major Stock Purchase in MoonLake Immunotherapeutics - TipRanks
MOONLAKE IMMUNOTHERAPEUTICS REMINDER: Bragar Eagel & - GlobeNewswire
Oklahoma City NewsThe Oklahoman - FinancialContent
Insider Stock Purchases: October 09, 2025 - Quiver Quantitative
MoonLake Immunotherapeutics Stock (MLTX) Opinions on Phase 3 Trial Setback - Quiver Quantitative
Bodenstedt, MoonLake CFO, buys $98k in MLTX stock By Investing.com - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Encourages MoonLake Immunotherapeutics (MLTX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Insider Buying: Matthias Bodenstedt Acquires Shares of MoonLake Immunotherapeutics - GuruFocus
Bodenstedt, MoonLake CFO, buys $98k in MLTX stock - Investing.com
BFA Law is Investigating MoonLake Immunotherapeutics (MLTX) for Securities Fraud and Urges Shareholders to Contact the Firm - Newsfile
Measuring MoonLake Immunotherapeutics’s beta against major indicesFed Meeting & Daily Growth Stock Tips - newser.com
Can Legal Pressures Reshape Confidence in MoonLake Immunotherapeutics’ (MLTX) R&D Pipeline? - Yahoo Finance
MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny - GlobeNewswire
MLTX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates - GlobeNewswire
MLTX INQUIRY NOTICE: MoonLake Immunotherapeutics Hit with - GlobeNewswire
MOONLAKE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):